Jun 17, 2015 7:15am EDT Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya as Proposed Brand Name for Cyclobenzaprine HCl Sublingual Tablets, 2.8 mg
Jun 16, 2015 7:15am EDT Tonix Pharmaceuticals Initiates Phase 2 Clinical Study of TNX-201 in Episodic Tension-Type Headache
Jun 11, 2015 7:00am EDT Tonix Pharmaceuticals Presents Additional Data From Phase 2b BESTFIT Clinical Study at EULAR
May 28, 2015 8:40am EDT Tonix Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference
May 26, 2015 3:45pm EDT Tonix Pharmaceuticals Announces Acceptance of Two Abstracts for Presentation at EULAR
May 15, 2015 9:00am EDT Tonix Pharmaceuticals Presents Data at the Annual Meeting of the Society for Biological Psychiatry
May 13, 2015 6:00am EDT Tonix Pharmaceuticals Launches Phase 3 Clinical Study of TNX-102 SL in Fibromyalgia
May 11, 2015 6:00am EDT Tonix Pharmaceuticals Reports First Quarter 2015 Financial Results and Clinical Update
Mar 20, 2015 11:30am EDT Tonix Pharmaceuticals to Present at the 12th Annual BIO Asia International Conference
